Wall Street was bracing for a weak nonfarm payrolls report Friday morning, and got it.

FORBES: U.S. Employment Stalls, Stocks Slide

Wall Street is bracing for one of the biggest new drug categories in a decade: the launch of a series of antiviral medicines that could dramatically improve the cure rate for hepatitis C, a viral disease that slowly attacks the liver and is often fatal.

FORBES

Researchers and Wall Street analysts are bracing for disappointment.

WSJ: For Alzheimer's, a Fork in the Road